lexingtonbiologo.jpg
Lexington Biosciences Receives HeartSentry USPTO Patent Approval
July 25, 2018 09:00 ET | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, July 25, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...